Aspirin for primary prevention of cardiovascular events in people with diabetes: a position statement of the American Diabetes Association, a scientific statement of the American Heart Association, and an expert consensus document of the American College of Cardiology Foundation

Diabetes Care. 2010 Jun;33(6):1395-402. doi: 10.2337/dc10-0555.
No abstract available

MeSH terms

  • American Heart Association
  • Aspirin / therapeutic use*
  • Cardiovascular Diseases / prevention & control*
  • Diabetes Complications / prevention & control*
  • Diabetes Mellitus / drug therapy*
  • Diabetes Mellitus / physiopathology
  • Humans
  • Platelet Aggregation Inhibitors / therapeutic use*
  • Societies, Medical
  • United States

Substances

  • Platelet Aggregation Inhibitors
  • Aspirin